HUMANA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.5 SEK | +2.33% |
|
+11.98% | +1.24% |
| Apr. 25 | Transcript : Humana AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
| Apr. 25 | Humana AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 3,236 | 2,988 | 3,554 | 1,841 | 1,346 | 1,363 | - | - |
| Enterprise Value (EV) 1 | 6,948 | 6,499 | 7,780 | 1,841 | 6,076 | 1,363 | 1,363 | 1,363 |
| P/E ratio | 17.2 x | 12 x | 12.8 x | 8.83 x | 7.57 x | 6.66 x | 5.92 x | 3.79 x |
| Yield | - | - | - | - | - | 2.32% | 4.65% | 4.91% |
| Capitalization / Revenue | 0.43 x | 0.38 x | 0.43 x | 0.2 x | 0.14 x | 0.13 x | 0.14 x | - |
| EV / Revenue | 0.43 x | 0.38 x | 0.43 x | 0.2 x | 0.14 x | 0.13 x | 0.14 x | - |
| EV / EBITDA | 4.68 x | 3.63 x | 3.88 x | 2.14 x | 1.38 x | 1.22 x | 1.16 x | - |
| EV / FCF | 10.5 x | 5.66 x | 6.11 x | - | 2.99 x | 3.64 x | 3.61 x | 3.25 x |
| FCF Yield | 9.52% | 17.7% | 16.4% | - | 33.5% | 27.4% | 27.7% | 30.7% |
| Price to Book | 1.42 x | 1.34 x | 1.51 x | - | 0.47 x | 0.45 x | 0.48 x | - |
| Nbr of stocks (in thousands) | 53,140 | 50,480 | 48,892 | 47,826 | 47,826 | 47,826 | - | - |
| Reference price 2 | 60.90 | 59.20 | 72.70 | 38.50 | 28.15 | 28.50 | 28.50 | 28.50 |
| Announcement Date | 2/13/20 | 2/11/21 | 2/10/22 | 2/9/23 | 2/8/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 7,467 | 7,797 | 8,188 | 9,241 | 9,728 | 10,397 | 9,430 | - |
| EBITDA 1 | 692 | 824 | 916 | 862 | 979 | 1,120 | 1,174 | - |
| EBIT 1 | 369 | 453 | 495 | 405 | 441 | 553.8 | 571.9 | - |
| Operating Margin | 4.94% | 5.81% | 6.05% | 4.38% | 4.53% | 5.33% | 6.06% | - |
| Earnings before Tax (EBT) 1 | 249 | 332 | 354 | 274 | 231 | 281.7 | 305.6 | - |
| Net income 1 | 188 | 262 | 276 | 210 | 176 | 217.5 | 238.4 | - |
| Net margin | 2.52% | 3.36% | 3.37% | 2.27% | 1.81% | 2.09% | 2.53% | - |
| EPS 2 | 3.540 | 4.940 | 5.670 | 4.360 | 3.720 | 4.278 | 4.815 | 7.520 |
| Free Cash Flow 1 | 308 | 528 | 582 | - | 451 | 374 | 378 | 419 |
| FCF margin | 4.12% | 6.77% | 7.11% | - | 4.64% | 3.6% | 4.01% | - |
| FCF Conversion (EBITDA) | 44.51% | 64.08% | 63.54% | - | 46.07% | 33.4% | 32.2% | - |
| FCF Conversion (Net income) | 163.83% | 201.53% | 210.87% | - | 256.25% | 171.99% | 158.56% | - |
| Dividend per Share 2 | - | - | - | - | - | 0.6618 | 1.325 | 1.400 |
| Announcement Date | 2/13/20 | 2/11/21 | 2/10/22 | 2/9/23 | 2/8/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2,110 | 2,147 | 2,241 | 2,373 | 2,480 | 2,467 | 2,410 | 2,398 | 2,397 | 2,407 |
| EBITDA 1 | - | 187 | 176 | 296 | 207 | 229 | 207 | 302 | 241 | 239 |
| EBIT 1 | 85 | 77 | 65 | 175 | 89 | 100 | 89 | 175 | 89 | 100 |
| Operating Margin | 4.03% | 3.59% | 2.9% | 7.37% | 3.59% | 4.05% | 3.69% | 7.3% | 3.71% | 4.15% |
| Earnings before Tax (EBT) 1 | 46 | 38 | 27 | 134 | 75 | 66 | 31 | 101 | 32 | 26 |
| Net income 1 | 33 | 29 | 18 | 104 | 60 | 51 | 38 | 82 | 7 | 21 |
| Net margin | 1.56% | 1.35% | 0.8% | 4.38% | 2.42% | 2.07% | 1.58% | 3.42% | 0.29% | 0.87% |
| EPS | 0.6800 | - | 0.3700 | 2.170 | 1.240 | 1.040 | 0.8000 | 1.710 | 0.1600 | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/10/22 | 5/5/22 | 8/18/22 | 11/10/22 | 2/9/23 | 5/4/23 | 7/21/23 | 10/27/23 | 2/8/24 | 4/25/24 |
1SEK in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | 3,712 | 3,511 | 4,226 | - | 4,730 | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 5.364 x | 4.261 x | 4.614 x | - | 4.831 x | - | - | - |
| Free Cash Flow 1 | 308 | 528 | 582 | - | 451 | 374 | 378 | 419 |
| ROE (net income / shareholders' equity) | 8.52% | 11.3% | 11.3% | - | 6.26% | 6.03% | 7.98% | - |
| ROA (Net income/ Total Assets) | 2.8% | 3.22% | 3.24% | - | 1.77% | - | 1.84% | - |
| Assets 1 | 6,714 | 8,137 | 8,523 | - | 9,918 | - | 12,935 | - |
| Book Value Per Share 2 | 43.00 | 44.30 | 48.00 | - | 60.30 | 63.40 | 58.90 | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 228 | 133 | 107 | - | 170 | 146 | 160 | 182 |
| Capex / Sales | 3.05% | 1.71% | 1.31% | - | 1.75% | 1.4% | 1.7% | - |
| Announcement Date | 2/13/20 | 2/11/21 | 2/10/22 | 2/9/23 | 2/8/24 | - | - | - |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
28.5
SEK
Average target price
35
SEK
Spread / Average Target
+22.81%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +1.24% | 124M | |
| -24.26% | 2.18B | |
| -1.23% | 1.41B | |
| -26.82% | 1.37B | |
| +15.23% | 706M | |
| -2.73% | 464M | |
| +240.37% | 432M | |
| -7.77% | 322M | |
| +39.04% | 88.82M |
- Stock Market
- Equities
- HUM Stock
- Financials Humana AB
